Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ADH1B | P00325 | 1/20 | 0.31 |
| ▸ | ADH1C | P00326 | 1/20 | 0.31 |
| ▸ | ADH1A | P07327 | 1/20 | 0.31 |
| ▸ | ADH4 | P08319 | 1/20 | 0.31 |
| ▸ | ADH7 | P40394 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3024354 | 0.98 | ADH1B (0.33) | LMNAADH1BADH1CADH1AADH4 | |
| SCHEMBL3038369 | 0.94 | TSHR (0.31) | TSHRSMN1; SMN2 | |
| SCHEMBL3024281 | 0.86 | ACE2 (0.36) | LMNAADH1BADH1CADH1AADH4 | |
| SCHEMBL94562 | 0.85 | — | — | |
| SCHEMBL3041307 | 0.80 | LMNA (0.40) | LMNA | |
| SCHEMBL16174549 | 0.80 | LMNA (0.54) | LMNA | |
| SCHEMBL5993537 | 0.79 | LMNA (0.31) | LMNA | |
| SCHEMBL5441114 | 0.79 | LMNA (0.31) | LMNATSHRSMN1; SMN2 | |
| SCHEMBL3024990 | 0.79 | TSHR (0.39) | LMNAADH1BADH1CADH1AADH4 | |
| SCHEMBL3033972 | 0.79 | TSHR (0.34) | LMNAADH1BADH1CADH1AADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1066 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12031079-B2 | Polymerisable LC medium and polymer film with flat optical dispersion | MERCK PATENT GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| CN-113039659-B | Self-assembled monolayers for electrode modification and devices comprising such self-assembled monolayers | 默克专利有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-105385453-B | Liquid-crystalline medium | 默克专利股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-4015598-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2024-05-22 | — | — | EP | disclosed |
| EP-3704176-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2024-05-15 | — | — | EP | disclosed |
| US-11958819-B2 | Compounds for optically active devices | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-04-16 | — | — | US | disclosed |
| CN-111247653-B | Electrode for electronic device comprising organic semiconductor layer | 弗莱克英纳宝技术有限公司 | 2024-04-09 | — | — | CN | disclosed |
| EP-3794650-B1 | ORGANIC SEMICONDUCTORS | RAYNERGY TEK INC (TW) | 2024-03-13 | — | — | EP | disclosed |
| EP-3994234-B1 | LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING THE SAME AND COMPOUNDS | MERCK PATENT GMBH (DE) | 2024-02-21 | — | — | EP | disclosed |
| WO-2024017812-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2024-01-25 | — | — | WO | disclosed |
| EP-0306521-A1 | ETHINE DERIVATIVES AS COMPOUNDS OF LIQUID CRYSTAL PHASES. | MERCK PATENT GMBH (DE) | 1989-03-15 | — | — | EP | disclosed |
| WO-1988009322-A1 | CYCLOBUTANE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-12-01 | — | — | WO | disclosed |
| WO-1988008441-A1 | ELECTRO-OPTICAL LIQUID CRYSTAL DISPLAY ELEMENT | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-11-03 | — | — | WO | disclosed |
| WO-1988007514-A1 | TOLANES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-10-06 | — | — | WO | disclosed |
| WO-1988007516-A1 | ETHINE DERIVATIVES AS COMPOUNDS OF LIQUID CRYSTAL PHASES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-10-06 | — | — | WO | disclosed |
| WO-1988007523-A1 | ACETYLENE DERIVATIVES AS COMPONENTS OF LIQUID CRYSTAL PHASES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-10-06 | — | — | WO | disclosed |
| EP-0281611-A1 | LIQUID CRYSTAL PHASES FOR ELECTRO-OPTIC DISPLAY ELEMENTS BASED ON THE ECB EFFECT. | MERCK PATENT GMBH (DE) | 1988-09-14 | — | — | EP | disclosed |
| EP-0269963-A2 | Ferroelectric liquid crystals | F. HOFFMANN-LA ROCHE AG (CH) | 1988-06-08 | — | — | EP | disclosed |
| EP-0235219-A1 | BICYCLO-OCTANE DERIVATIVES | MERCK PATENT GmbH (DE) | 1987-09-09 | — | — | EP | disclosed |
| WO-1987001113-A1 | BICYCLO-OCTANE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1987-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11958819-B2 | Compounds for optically active devices | PDE6C, ALDH1A2, PDE6A | LMNA 3184/4885ADH1B 2421/4885ADH1C 2768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.